Clinical Trials on Hip Prosthetic Joint Infection in Canada

Total 658 results

Gilead Sciences

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance (CAPELLA)

HIV-1-infection

United States, Spain, France, Taiwan, Japan, Thailand, Dominican Republic, Germany, Canada, Italy, South Africa
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression

Osteoarthritis

France, Canada
Unity Health Toronto

Unknown

Decision Support Intervention Adapted for HIV Pre-Exposure Prophylaxis for Adoption and Adherence for Black Canadians (PrEPDSA)

HIV/AIDS

Canada
Vancouver Infectious Diseases Centre

Unknown

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed

Drug Use | Human Immunodeficiency Virus I Infection

Canada
Janssen Inc.

Completed

An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients (POISE)

Human Immunodeficiency Virus (HIV)

Canada
McGill University

Not yet recruiting

Action for Brain Health Now: Ready, Set, Go

Hiv

Canada
University of British Columbia
Health Canada

Completed

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

HIV Infections | HIV

Canada
Glaxo Wellcome

Completed

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

HIV Infections

United States, Canada, Argentina, Brazil, Puerto Rico
University of Valencia
Hoffmann-La Roche

Unknown

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Chronic Hepatitis C | Co-Infection HIV-HCV

Spain
McGill University Health Centre/Research Institute...
AbbVie; Prometheus Laboratories

Completed

The SpACE Study - Small Bowel Crohn's Disease and Spondyloarthropathies (SpACE)

Crohn Disease | Spondyloarthropathy

Canada
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

HIV Infections

Canada
Ryerson University
Canadian Institutes of Health Research (CIHR); Ottawa Hospital Research Institute and other collaborators

Completed

GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men

HIV/AIDS | Health Behavior | Sexually Transmitted Infection

Canada
Unity Health Toronto

Completed

HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy

Pregnancy | HIV | AIDS Virus

Canada
McGill University Health Centre/Research Institute...
Université de Montréal; Argos Therapeutics

Completed

A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.

Acquired Immunodeficiency Syndrome | HIV Seropositivity

Canada
Unity Health Toronto
Gilead Sciences; Ryerson University; Maple Leaf Research; AIDS Committee of Toronto and other collaborators

Completed

PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 (PREP-5)

HIV | Human Immunodeficiency Virus

Canada
Bristol-Myers Squibb

Terminated

Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive

HIV-1 Infection

Thailand, United States, Australia, Canada, Spain, Colombia, South Africa, Hungary, France, Peru, Argentina, Chile, Mexico
NicOx

Completed

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip

Osteoarthritis | Osteoarthritis, Hip

United States, Canada
Gilead Sciences

Recruiting

Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)

HIV-1-infection

United States, France, Canada
Pfizer
ViiV Healthcare

Terminated

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

HIV-1

South Africa, Australia, United Kingdom, Canada, Italy, Poland, Switzerland, Mexico, Brazil
University of Toronto

Completed

Transgender Education for Affirmative and Competent HIV and Healthcare (TEACHH)

HIV/AIDS | Stigma, Social | Health Care Acceptability

Canada
Unity Health Toronto

Completed

Fetal HIV Transmission Risk and Duration of Membrane Rupture

HIV | Human Immunodeficiency Virus

Canada
Vancouver Infectious Diseases Centre
Gilead Sciences; Regina General Hospital

Unknown

STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY) (SINNR)

HIV | Illicit Drug User

Canada
National Institute of Allergy and Infectious Diseases...

Completed

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised

HIV Infections

United States, Canada
Unity Health Toronto

Unknown

Using Electronic Medical Record Data to Improve HIV Primary Care

HIV/AIDS | Electronic Health Records | Quality of Health Care

Canada
Canadian Immunodeficiency Research Collaborative
Hoffmann-La Roche

Completed

Fuzeon Viral Decay Pilot Study

HIV-1

Canada
Fundacion SEIMC-GESIDA
Janssen, LP

Completed

Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject (DUAL)

HIV Infection

Spain
Unity Health Toronto
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

HIV Infections | HIV Testing

Canada
Hoffmann-La Roche

Completed

A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
Genzyme, a Sanofi Company

Completed

A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip

Osteoarthritis, Hip

United States, Canada
AbbVie

Completed

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

HIV Infection | HIV-1 | Human Immunodeficiency Virus (HIV)

United States, Australia, Canada, Puerto Rico
Ottawa Heart Institute Research Corporation
Ontario HIV Treatment Network

Completed

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Human Immunodeficiency Virus (HIV) | Cardiovascular Disease (CVD)

Canada
Sociedad Andaluza de Enfermedades Infecciosas

Completed

Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor (QoLKAMON)

HIV Infection

Spain
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

HIV Infections | Tuberculosis

United States, Canada
Unity Health Toronto
CIHR Canadian HIV Trials Network

Completed

Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial (BATARI)

HIV

Canada
Virginia Commonwealth University

Completed

HBV-HIV Coinfection Research Network

Hepatitis B | Human Immunodeficiency Virus

United States, Canada
University Health Network, Toronto
Canadian Institutes of Health Research (CIHR); University of Toronto

Completed

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2? (VALIANT Pilot)

Herpes Simplex | Human Immunodeficiency Virus

Canada
McGill University
Posit Science Corporation

Completed

Cognitive Training for the Remediation of Functional Brain Health in HIV

Cognitive Impairment | HIV - Human Immunodeficiency Virus

Canada
Kinevant Sciences GmbH

Completed

Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis

Inflammation | Rheumatic Diseases

Canada
Gilead Sciences

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection (DISCOVER)

Pre-Exposure Prophylaxis of HIV-1 Infection

United States, Austria, Denmark, United Kingdom, Netherlands, Italy, Germany, Canada, Ireland, France, Spain
Unity Health Toronto

Terminated

Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia (HOPE-Hb)

Anemia, Iron Deficiency | Knee Arthropathy | Hip Arthropathy | Anemia of Chronic Disease

Canada
Janssen R&D Ireland

Completed

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

HIV-1 Infection

United States, Australia, France, United Kingdom, China, Belgium, Germany, Spain, Argentina, Romania, South Africa, Canada, Denmark, Netherlands, Chile, Puerto Rico, Austria, Russian Federation, Thailand, Sweden, Taiwan
University of South Florida
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

Arthritis, Reactive | Reiter Disease

United States, Canada
University of British Columbia
Boehringer Ingelheim; Abbott; CIHR Canadian HIV Trials Network

Completed

NRTI-Sparing Pilot Study

HIV | Mitochondrial Toxicity

Canada
McGill University Health Centre/Research Institute...
Merck Sharp & Dohme LLC

Completed

Protease Inhibitor vs. Raltegravir-based ART and Inflammation in HIV Infection

HIV

Canada
National Institute of Allergy and Infectious Diseases...
Chiron Corporation

Completed

An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy (ESPRIT)

HIV Infections

United States, Brazil, Australia, Argentina, Austria, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Japan, Morocco, Netherlands, Norway, Poland, Portugal, Singapore, Spain, Sweden, Switzerland, Thailand, United Kingdom
Maple Leaf Research

Recruiting

Drug-Drug Interaction Study in Trans Women Living With HIV (T-DDI)

Hiv | Transgenderism

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network

Unknown

The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers (CANQUIT)

Smoking Cessation | HIV

Canada
Lawson Health Research Institute

Completed

Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies

HIV Infections | Cancer, Second Primary

Canada
HQ Toronto
Gilead Sciences

Active, not recruiting

Express Testing and Same-day Initiation of PrEP Study (Express-PrEP)

HIV Prevention

Canada
Marie-Josée Brouillette
Fonds de la Recherche en Santé du Québec; CIHR Canadian HIV Trials Network

Terminated

COMO: Cognition Study With HIV+ Patients (CTNPT 015) (COMO)

HIV - Human Immunodeficiency Virus | Cognitive Symptoms

Canada

Clinical Trials on Hip Prosthetic Joint Infection in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations